Search Bar & Filters
Found 1 Actively Recruiting clinical trials
Actively Recruiting
This research aims to evaluate the rate of malposition and related clinical outcomes of the Hydrus Microstent implant in patients with primary open-angle glaucoma undergoing cataract surgery. The study focuses on patients with age-related cataracts and glaucoma managed with up to four topical medications, assessing device placement and safety over a 24-month period after surgery. Participants will undergo cataract surgery with placement of a monofocal intraocular lens followed immediately by implantation of the Hydrus Microstent device. The Hydrus Microstent is a crescent-shaped implant designed to create a pathway for fluid drainage in the eye. The study is a single-group, non-randomized clinical trial where all participants receive this combined treatment. During the study, participants will attend a screening visit, the surgery day, and eight post-operative visits scheduled from Day 1 through Month 24 to monitor device position and associated clinical effects. Researchers will track adverse events during surgery and post-operation and measure the rate of significant device malposition linked to clinical outcomes. The study is sponsored by Alcon Research and lasts up to 24 months post-surgery.